Our Hodgkin Lymphoma Program is led by pediatric experts in hematology oncology, radiology, pathology, and radiation oncology. We evaluate, diagnose, and treat children with all forms of Hodgkin lymphoma and related disorders.
Children with newly diagnosed and recurrent Hodgkin lymphoma are treated through Dana-Farber/Boston Children's Cancer and Blood Disorders Center's Hodgkin Lymphoma Program. Our program is led by pediatric experts in hematology oncology, radiology, pathology and radiation oncology.
Through our program, your child will be treated by some of the world’s most experienced pediatric oncologists at Dana-Farber Cancer Institute and internationally recognized pediatric subspecialists at Boston Children’s Hospital.
The Hodgkin Lymphoma Program combines the expertise of both Boston Children's Hospital, one of the top pediatric hospitals in the country, and Dana-Farber Cancer Institute, a national leader in cancer care.
Our multidisciplinary care team is made up of specialists with specific expertise in pediatric lymphomas, including:
We evaluate, diagnose and treat children with all forms of Hodgkin lymphoma and related disorders. We also provide consultation services and long-term follow-up for pediatric and adolescent patients.
If your child has been diagnosed with Hodgkin lymphoma, you probably have a lot of questions about treatment and care options. Our program offers the latest treatments for Hodgkin lymphoma and our researchers work continuously to develop and refine therapies. We offer:
We offer comprehensive multidisciplinary consultation services to physicians and families at the time of diagnosis, on therapy, at relapse, and in follow-up.
Other services we provide include:
Like all patients who were treated with chemotherapy and/or radiation, survivors of childhood Hodgkin lymphoma may be at risk of developing health problems later in life. It is particularly important for childhood Hodgkin lymphoma survivors who receive radiation to the torso area as part of their cancer treatment to be screened for late effects, including breast cancer and cardiac complications.
To help patients monitor their overall health after treatment is completed, we encourage children and adolescents to continue long-term care through Dana-Farber's David B. Perini Jr. Quality of Life Clinic.
At the Hodgkin Lymphoma Program, we have a staff of compassionate and experienced pediatric subspecialists that includes oncologists, radiation oncologists, radiologists and surgeons.
Our physicians are focused on family-centered care. From your first visit, you’ll work with a team of professionals who are committed to supporting all of your family’s physical and psychosocial needs.
Thanks to advances in research and care, the outcomes for children with Hodgkin lymphoma have improved dramatically in recent decades. Today, the majority of pediatric Hodgkin patients can expect to be cured of their disease. We are dedicated to improving therapies further by reducing the toxicity and long-term side effects of treatment.
It’s possible that your child will be eligible to participate in one of our current clinical trials. These studies are useful for many reasons: some trials are designed to evaluate the effectiveness of a particular drug, treatment, or therapy on a specific disease; others help doctors to better understand how and why certain conditions occur. At any given time, we have hundreds of clinical trials underway.
Dana-Farber Cancer Institute is a founding member of a small national consortium of leading medical centers that investigates new treatments for children with Hodgkin lymphoma. Through this consortium, Dana-Farber/Boston Children's physicians are investigating new drug combinations that deliver results with fewer long-term complications.
In addition, we offer access to all Children's Oncology Group's Phase I clinical trials and other trials for relapsed Hodgkin lymphoma.
Referring physicians: 617-632-5508 or 1-888-Pedi-Onc (733-4662)
We understand a cancer diagnosis is extremely difficult to cope with. We are available to offer a consultation or second opinion for your child.
If your child has been diagnosed with Hodgkin lymphoma, please contact our program at 888-PEDI-ONC (888-733-4662).
To help us conduct a precise evaluation, it’s important we receive a full summary of your child's initial diagnosis. This includes any laboratory or pathology reports, any x-ray, radiographic or MRI images and a list of any previous treatments your child may have received. We will work with you and any other treating physicians to obtain the necessary information prior to the visit, including:
Complete clinical summary
Boston Children's Hospital300 Longwood AvenueBoston, MA 02115
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215
Browse clinical trials
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free:
(866) 408-DFCI (3324)